Rheos Capital Works Inc. Trims Stock Holdings in CME Group Inc. (NASDAQ:CME)

Rheos Capital Works Inc. decreased its holdings in shares of CME Group Inc. (NASDAQ:CMEFree Report) by 43.5% during the first quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 68,800 shares of the financial services provider’s stock after selling 53,000 shares during the quarter. Rheos Capital Works Inc.’s holdings in CME Group were worth $14,812,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Several other institutional investors have also recently made changes to their positions in the stock. Gold Investment Management Ltd. purchased a new position in CME Group during the 4th quarter valued at about $26,000. Northwest Financial Advisors purchased a new stake in CME Group in the 4th quarter worth approximately $28,000. Harbor Investment Advisory LLC boosted its holdings in CME Group by 966.7% in the 4th quarter. Harbor Investment Advisory LLC now owns 160 shares of the financial services provider’s stock valued at $34,000 after purchasing an additional 145 shares during the period. BKM Wealth Management LLC purchased a new position in shares of CME Group during the 4th quarter valued at $38,000. Finally, Atticus Wealth Management LLC bought a new position in shares of CME Group in the third quarter worth $40,000. Hedge funds and other institutional investors own 87.75% of the company’s stock.

CME Group Stock Down 2.0 %

CME Group stock traded down $4.01 during trading hours on Friday, hitting $194.48. 5,763,948 shares of the stock traded hands, compared to its average volume of 1,893,577. CME Group Inc. has a one year low of $177.97 and a one year high of $223.80. The firm’s 50-day moving average price is $206.64 and its two-hundred day moving average price is $209.20. The company has a current ratio of 1.01, a quick ratio of 1.01 and a debt-to-equity ratio of 0.10. The company has a market cap of $70.03 billion, a PE ratio of 22.13, a PEG ratio of 5.25 and a beta of 0.52.

CME Group (NASDAQ:CMEGet Free Report) last released its earnings results on Wednesday, April 24th. The financial services provider reported $2.50 earnings per share for the quarter, topping analysts’ consensus estimates of $2.44 by $0.06. CME Group had a net margin of 56.84% and a return on equity of 12.45%. The firm had revenue of $1.49 billion for the quarter, compared to the consensus estimate of $1.48 billion. During the same period in the prior year, the firm earned $2.42 EPS. The company’s revenue was up 3.2% compared to the same quarter last year. On average, research analysts forecast that CME Group Inc. will post 9.72 EPS for the current year.

CME Group Dividend Announcement

The firm also recently announced a quarterly dividend, which will be paid on Tuesday, June 25th. Stockholders of record on Friday, June 7th will be issued a dividend of $1.15 per share. The ex-dividend date of this dividend is Friday, June 7th. This represents a $4.60 annualized dividend and a dividend yield of 2.37%. CME Group’s payout ratio is 52.33%.

Analyst Ratings Changes

CME has been the subject of several research analyst reports. Bank of America lifted their target price on shares of CME Group from $209.00 to $216.00 and gave the company a “neutral” rating in a research report on Thursday, April 25th. Rosenblatt Securities reissued a “sell” rating and issued a $187.00 target price (up previously from $185.00) on shares of CME Group in a research note on Thursday, April 25th. JPMorgan Chase & Co. lowered CME Group from a “neutral” rating to an “underweight” rating and dropped their price objective for the company from $206.00 to $187.00 in a research note on Friday. Deutsche Bank Aktiengesellschaft restated a “hold” rating and issued a $210.00 target price (down previously from $235.00) on shares of CME Group in a report on Friday, April 5th. Finally, Keefe, Bruyette & Woods upped their price target on shares of CME Group from $222.00 to $226.00 and gave the company a “market perform” rating in a report on Thursday, April 25th. Three equities research analysts have rated the stock with a sell rating, six have issued a hold rating and two have given a buy rating to the company. Based on data from MarketBeat, the stock has an average rating of “Hold” and an average price target of $215.90.

Read Our Latest Analysis on CME Group

Insider Transactions at CME Group

In other CME Group news, Director Charles P. Carey sold 3,000 shares of the stock in a transaction on Thursday, June 13th. The stock was sold at an average price of $195.44, for a total transaction of $586,320.00. Following the sale, the director now directly owns 7,163 shares in the company, valued at approximately $1,399,936.72. The sale was disclosed in a document filed with the SEC, which is accessible through the SEC website. In other CME Group news, Director Daniel R. Glickman sold 650 shares of the stock in a transaction dated Thursday, June 6th. The stock was sold at an average price of $201.44, for a total value of $130,936.00. Following the transaction, the director now owns 14,008 shares of the company’s stock, valued at $2,821,771.52. The transaction was disclosed in a filing with the SEC, which can be accessed through this hyperlink. Also, Director Charles P. Carey sold 3,000 shares of the business’s stock in a transaction dated Thursday, June 13th. The shares were sold at an average price of $195.44, for a total value of $586,320.00. Following the sale, the director now owns 7,163 shares of the company’s stock, valued at $1,399,936.72. The disclosure for this sale can be found here. Insiders have sold a total of 54,290 shares of company stock valued at $11,393,700 in the last ninety days. 0.30% of the stock is currently owned by corporate insiders.

CME Group Company Profile

(Free Report)

CME Group Inc, together with its subsidiaries, operates contract markets for the trading of futures and options on futures contracts worldwide. It offers futures and options products based on interest rates, equity indexes, foreign exchange, agricultural commodities, energy, and metals, as well as fixed income and foreign currency trading services.

Featured Articles

Institutional Ownership by Quarter for CME Group (NASDAQ:CME)

Receive News & Ratings for CME Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CME Group and related companies with MarketBeat.com's FREE daily email newsletter.